Effects of Obesity Reduction on Cardiovascular Risk Factors: Comparison of Individual and Group Treatment - Substudy of the Croatian Healthy Weight Loss Programme

被引:0
|
作者
Jovanovic, Zeljko [3 ]
Crncevic-Orlic, Zeljka [2 ]
Stimac, Davor [2 ]
Kokic, Slaven [1 ]
Persic, Viktor [5 ]
Ruzic, Tatjana [4 ]
Goll-Baric, Sanda [3 ]
机构
[1] Univ Hosp Ctr Split, Clin Internal Med, Split 21000, Croatia
[2] Univ Hosp Ctr Rijeka, Rijeka, Croatia
[3] Healthy Weight Loss Project Rijeka, Rijeka, Croatia
[4] Psychiat Hosp Rab, Kampor, Croatia
[5] Thalasotherapia, Opatija, Croatia
关键词
cardiovascular diseases; obesity; orlistat; program evaluation; weight loss; DISEASE RISK; ORLISTAT;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Prevention of obesity may help reduce the morbidity and mortality from cardiovascular diseases. In Croatia, over half of adult population is overweight. Aldo the basic medical principles of healthy weight-loss programmes are well known, it is believed that mainly because of the leak of successful therapeutic approach obesity remains the most challenging changeable cardiovascular risk factor in nowadays clinical practice. Objective of this Croatian Healthy Weight Loss Programme substudy was to determine effects and differences between the intensive group and intensive individual weight-loss program on weight loss and cardiovascular risk factor A clinical trial included 476 adults whose body mass index (BMI) was >30 or >28 accompanied by increased blood pressure, glucose, and cholesterol. The study participants completed either a group (n = 243) or individually-based (n = 233) 6-month weight-loss program consisting of education, low-fat diet, pharmacological treatment with orlistat, psychological counselling, and exercise. Body weight, body mass index, blood pressure, blood sugar and blood cholesterol were measured in all participants after 3 and 6 months. The average weight loss was 12.2 (13%) kg and 7.6 (9%) kg in the group and individual program, respectively. Beside the weight reduction, the levels of blood cholesterol, glucose, and blood pressure were also significantly reduced in comparison with baseline, decreasing to normal values in all participants (P<0.001 for all). Decrease in the monitored parameters was greater in participants in the group program. The weight loss program provided a healthy loss of extra weight in the period of 6 months. The group program produced greater decrease in body weight, body mass index, blood pressure, glucose, and cholesterol than the individual program.
引用
收藏
页码:751 / 757
页数:7
相关论文
共 43 条
  • [31] Low-Fat Versus Low-Carbohydrate Weight Reduction Diets Effects on Weight Loss, Insulin Resistance, and Cardiovascular Risk: A Randomized Control Trial
    Bradley, Una
    Spence, Michelle
    Courtney, C. Hamish
    McKinley, Michelle C.
    Ennis, Cieran N.
    McCance, David R.
    McEneny, Jane
    Bell, Patrick M.
    Young, Ian S.
    Hunter, Steven J.
    DIABETES, 2009, 58 (12) : 2741 - 2748
  • [32] The effects of Mediterranean diet on cardiovascular risk factors, glycemic control and weight loss in patients with type 2 diabetes: a meta-analysis
    Zheng, Xing
    Zhang, Wenwen
    Wan, Xiaojuan
    Lv, Xiaoyan
    Lin, Peng
    Si, Shucheng
    Xue, Fuzhong
    Wang, Aijun
    Cao, Yingjuan
    BMC NUTRITION, 2024, 10 (01)
  • [33] Effects of a 12-Week Web-Based Weight Loss Program for Adults With Overweight and Obesity on COVIDAge and Lifestyle-Related Cardiometabolic Risk Factors: A Randomized Controlled Trial
    Brame, Judith
    Centner, Christoph
    Berg, Niklas
    Bartlam, Matt
    Gollhofer, Albert
    Koenig, Daniel
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [34] INTERACTIONS BETWEEN THE EFFECTS OF EXERCISE AND WEIGHT-LOSS ON RISK-FACTORS, CARDIOVASCULAR HEMODYNAMICS AND LEFT-VENTRICULAR STRUCTURE IN OVERWEIGHT SUBJECTS
    REID, CM
    DART, AM
    DEWAR, EM
    JENNINGS, GL
    JOURNAL OF HYPERTENSION, 1994, 12 (03) : 291 - 301
  • [35] Effects of lupin-enriched foods on body composition and cardiovascular disease risk factors: a 12-month randomized controlled weight loss trial
    R Belski
    T A Mori
    I B Puddey
    S Sipsas
    R J Woodman
    T R Ackland
    L J Beilin
    E R Dove
    N B Carlyon
    V Jayaseena
    J M Hodgson
    International Journal of Obesity, 2011, 35 : 810 - 819
  • [36] Effects of lupin-enriched foods on body composition and cardiovascular disease risk factors: a 12-month randomized controlled weight loss trial
    Belski, R.
    Mori, T. A.
    Puddey, I. B.
    Sipsas, S.
    Woodman, R. J.
    Ackland, T. R.
    Beilin, L. J.
    Dove, E. R.
    Carlyon, N. B.
    Jayaseena, V.
    Hodgson, J. M.
    INTERNATIONAL JOURNAL OF OBESITY, 2011, 35 (06) : 810 - 819
  • [37] Effects of a 3-Week In-Hospital Body Weight Reduction Program on Cardiovascular Risk Factors, Muscle Performance, and Fatigue: A Retrospective Study in a Population of Obese Adults with or without Metabolic Syndrome
    Rigamonti, Antonello E.
    Cicolini, Sabrina
    Caroli, Diana
    De Col, Alessandra
    Scacchi, Massimo
    Cella, Silvano G.
    Sartorio, Alessandro
    NUTRIENTS, 2020, 12 (05)
  • [38] Effects of Breastfeeding Promotion Intervention and Dietary Treatment in Postpartum Women with Overweight and Obesity: Results from a Randomized Controlled Trial on Weight and Cardiometabolic Risk Factors
    Ohman, Elisabeth A.
    Fossli, Maria
    Rasmussen, Kathleen M.
    Winkvist, Anna
    Loland, Beate F.
    Holven, Kirsten B.
    Brekke, Hilde K.
    JOURNAL OF NUTRITION, 2024, 154 (08) : 2448 - 2458
  • [39] Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy
    da Silveira Campos, Raquel Munhoz
    Landi Masquio, Deborah Cristina
    Corgosinho, Flavia Campos
    Caranti, Danielle Arisa
    Ganen, Aline de Piano
    Tock, Lian
    Oyama, Lila Missae
    Damaso, Ana Raimunda
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (02) : 196 - 206
  • [40] A study on the genetics of obesity:: Influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip ratio and frequencies of common cardiovascular risk factors
    Benecke, H
    Topak, H
    zur Mühlen, AV
    Schuppert, F
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2000, 108 (02) : 86 - 92